{"task_id": "47a5d6fc062d18e8", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 257/464)", "text": "act Infections and Sexually Transmitted Infections\n\n--- Page 268 ---\nSoft Tissue Infections\nNEJM 2004 350:9; NEJM 2007 357:4;\nCID 2005 41:10\nDIFFERENTIAL DIAGNOSIS\nDISCRETE,\nLOCALIZED\nCUTANEOUS\nINFEC\nTIONS\nsuperficial (impetigo, folliculitis, furuncu\nlosis), deep (carbuncles, subcutaneous abscesses)\nSPREADING, DIFFUSE CUTANEOUS INFECTIONS\n(involves deeper dermis and subcutaneous tis\nsues)\nerysipelas, cellulitis\nDEEP SOFT TISSUE INFECTIONS\nnecrotizing\nfasciitis (polymicrobial, S. pyogenes), gas gangrene\n(C. perfringens)\nPATHOPHYSIOLOGY\nRISK FACTORS FOR CELLULITIS\n\u0002\nCOMPROMISED\nSKIN\ntrauma,\nIDU,\npsoriasis,\neczema, fungal disease (especially tinea pedis)\n\u0002\nCOMPROMISED\nSENSORY/PROPRIOCEPTIVE\nNERVES\ndiabetic neuropathy\n\u0002\nCOMPROMISED BLOOD/LYMPHATIC VESSELS\ndiabetes,\nmalignancy, lymphatic or venous insufficiency,\nvenectomy, radiation, prior cellulitis\nCELLULITIS\nacute spreading infection involving\nthe dermis and subcutaneous tissue, mostly caused\nby Staphylococci and group A Streptococcus. It usually\npresents as a swollen, erythematous plaque with ill\ndefined border\nERYSIPELAS\nsuperficial cellulitis involving the\nupper dermis and lymphatics, mostly caused by\ngroup A Streptococcus. It usually presents as a\nraised, erythematous plaque with well demar\ncated border. It occurs more commonly in infants\nand elderly\nRISK FACTORS FOR SKIN AND SOFT TISSUE INFEC\nTIONS DUE TO MRSA/CA MRSA\nprevious MRSA\ninfection or household contacts of known MRSA;\nstreet involved/shelters/incarceration, injection drug\nuse, athletes, children/day care\nCOMMON PATHOGENS CAUSING CELLULITIS\n\u0002\nMOST COMMON\nS. pyogenes (b hemolytic group A\nStreptococcus), S. aureus, other b hemolytic strep\ntococci (B, C, G, and F)\n\u0002\nSURGICAL WOUND\nS. aureus, S. pyogenes\n\u0002\nHUMAN BITE\noral anaerobes, Eikenella corrodens\n\u0002\nANIMAL\nBITE\nPasteurella multocida, Capnocyto\nphaga canimorsus\n\u0002\nTICK BITE\nBorrelia burgdorferi, Tularemia\n\u0002\nFRESHWATER\nAeromonas hydrophila\n\u0002\nSEAWATER\nVibrio vulnificus\n\u0002\nFISH EXPOSURE\nErysipelothrix rhusiopathiae, Strep\ntococcus iniae\n\u0002\nHOT TUB\nPseudomonas aeruginosa folliculitis\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, lactate (if suspicion\nof necrotizing fasciitis)\n\u0002\nMICROBIOLOGY\nswab of portal of entry or any\nopen wound for Gram stain and C&S, blood C&S\nMANAGEMENT\nTREAT UNDERLYING CAUSE\nincision and drai\nnage of abscesses. Elevation of affected area if\npossible, compression and skin hydration. Antibiotics\nfor mild cellulitis (cephalexin 500 mg PO QID, diclox\nacillin 500 mg PO QID, or clindamycin 150 300 mg PO\nQID \u00055 14 days); for systemic toxicity or severe\ncellulitis (cefazolin 1 2 g IV q8h, ceftriaxone 1 g IV\nq24h, nafcillin 1 2 g IV q4 6h \u00057 14 days). For MRSA\nassociated skin infections, consider vancomycin 1 2 g\nIV q12h, clindamycin 600 mg IV TID or 300 mg PO QID,\ndaptomycin 4 6 mg/kg IV daily, tigecycline 100 mg\nloading dose, then 50 mg IV q12h, doxycycline\n100 mg PO BID, linezolid 600 mg PO/IV q12h or\nquinupristin dalfopristin 7.5 mg/kg IV q8 12h. For\nmild erysipelas, consider penicillin 500 mg PO QID\nor amoxicillin 500 mg PO TID. For severe erysipelas\nwith fevers and chills, consider ceftriaxone 1 g IV q24h\nor cefazolin 1 2 g IV q8h \u00055 14 days\nSPECIFIC ENTITIES\nNECROTIZING FASCIITIS\n\u0002\nTYPES\ntype 1 (polymicrobial infections including\nEnterococci, E. coli, non group A Streptococcus,\nKlebsiella, anaerobes. Mixed infections occurring\npostoperatively or in those with diabetes or per\nipheral vascular disease, e.g. Fournier\u2019s gangrene\nof perineum in diabetics), type 2 (monomicrobial\nStreptococcus pyogenes \u2018\u2018Group A strep\u2019\u2019; rarely, CA\nMRSA. May occur at any age and in healthy hosts\nfollowing minor trauma, penetrating injury, lacera\ntion, varicella, IDU, or childbirth)\n\u0002\nPATHOPHYSIOLOGY\n(type\n1)\ninoculation\nof\nischemic or devitalized tissue ! host immune\nsystem and antibiotics relatively ineffective !\nrapid spreading of infection to surrounding tissue\n! late signs include fever, crepitus, shock !\ncomplications include compartment syndrome,\nacute renal failure, sepsis. May be limb or life\nthreatening. May happen over a few hours\n\u0002\nASSOCIATIONS\nhost (age >50, cancer, alcoholism,\nimmunocompromised state, malnutrition, obe\nsity), compromised skin (burns, trauma, postopera\ntive infection), compromised blood vessels (per\nipheral vascular disease, diabetes)\nSoft Tissue Infections\n247", "text_length": 4327, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 257/464)", "type": "chunk", "chunk_index": 256, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.601160", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.601895", "status": "complete", "chunks_added": 3}